Search research articles
Contact Us
Filters
Showing results (91-100 of 217) with videos related to
Page
of 22
Sort By:
Investigational New Drugs
|
December 31, 2009
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction
Dok Hyun Yoon, Hyo Jung Lee, Yong Sang Hong, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 1, 2012
A positron emission tomography microdosing study with sertraline in healthy volunteers
Kwang-Hee Shin, Kyu-Pyo Kim, Kyoung Soo Lim, et al.
Targeted Oncology
|
September 27, 2019
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study
Jwa Hoon Kim, Sun Young Kim, Kyu-Pyo Kim, et al.
Oncotarget
|
October 21, 2016
Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model
Si Yeol Song, Kyu-Pyo Kim, Seong-Yun Jeong, et al.
Investigational New Drugs
|
March 10, 2018
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy
Hyungwoo Cho, Dok Hyun Yoon, Kyu-Pyo Kim, et al.
Cancer Chemotherapy and Pharmacology
|
April 19, 2013
A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer
Kyu-pyo Kim, Ho-Sook Kim, Sun Jin Sym, et al.
Clinical Therapeutics
|
March 9, 2010
Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers
Bo-Hyung Kim, Kyu-Pyo Kim, Kyoung Soo Lim, et al.
Journal of Hepatology
|
March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials
Changhoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
International Journal of Oncology
|
May 4, 2012
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1
Yong Sang Hong, Seung-Woo Hong, Seung-Mi Kim, et al.
Cancer Research and Treatment
|
April 12, 2022
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
Jihoon Kang, Ji-Young Lee, Sunmin Lee, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 217) with videos related to
Sort By:
Page
of 22
Investigational New Drugs
|
December 31, 2009
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction
Dok Hyun Yoon, Hyo Jung Lee, Yong Sang Hong, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 1, 2012
A positron emission tomography microdosing study with sertraline in healthy volunteers
Kwang-Hee Shin, Kyu-Pyo Kim, Kyoung Soo Lim, et al.
Targeted Oncology
|
September 27, 2019
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study
Jwa Hoon Kim, Sun Young Kim, Kyu-Pyo Kim, et al.
Oncotarget
|
October 21, 2016
Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model
Si Yeol Song, Kyu-Pyo Kim, Seong-Yun Jeong, et al.
Investigational New Drugs
|
March 10, 2018
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy
Hyungwoo Cho, Dok Hyun Yoon, Kyu-Pyo Kim, et al.
Cancer Chemotherapy and Pharmacology
|
April 19, 2013
A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer
Kyu-pyo Kim, Ho-Sook Kim, Sun Jin Sym, et al.
Clinical Therapeutics
|
March 9, 2010
Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers
Bo-Hyung Kim, Kyu-Pyo Kim, Kyoung Soo Lim, et al.
Journal of Hepatology
|
March 27, 2025
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials
Changhoon Yoo, Anna Saborowski, Jaewon Hyung, et al.
International Journal of Oncology
|
May 4, 2012
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1
Yong Sang Hong, Seung-Woo Hong, Seung-Mi Kim, et al.
Cancer Research and Treatment
|
April 12, 2022
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
Jihoon Kang, Ji-Young Lee, Sunmin Lee, et al.
Page
of 22